AAAAAA
Results:
1-14
|
Results: 14
Authors:
Kreidberg, JA
Natoli, TA
Citation: Ja. Kreidberg et Ta. Natoli, Animal models for tumor suppressor genes, CANC DRUG, 2000, pp. 3-28
Authors:
Chellappan, SP
Citation: Sp. Chellappan, Viral oncoproteins as probes for tumor suppressor function, CANC DRUG, 2000, pp. 29-48
Authors:
Ouatas, T
Hartsough, MT
Steeg, PS
Citation: T. Ouatas et al., Tumor suppressors in metastasis, CANC DRUG, 2000, pp. 49-77
Authors:
Du, JY
Fisher, DE
Citation: Jy. Du et De. Fisher, Apoptosis - Machinery of cell death in development and cancer, CANC DRUG, 2000, pp. 79-101
Authors:
Matter, A
Citation: A. Matter, Drug discovery in oncology, CANC DRUG, 2000, pp. 103-128
Authors:
Stepanova, L
Harper, JW
Citation: L. Stepanova et Jw. Harper, Retinoblastoma protein in growth control and differentiation, CANC DRUG, 2000, pp. 131-157
Authors:
Ashcroft, M
Vousden, KH
Citation: M. Ashcroft et Kh. Vousden, p53 tumor suppressor protein, CANC DRUG, 2000, pp. 159-181
Authors:
Kamb, A
McCormack, K
Citation: A. Kamb et K. Mccormack, p16 tumor suppressor, CANC DRUG, 2000, pp. 183-195
Authors:
Li, GM
McCulloch, S
Gu, LY
Citation: Gm. Li et al., DNA mismatch repair in tumor suppression, CANC DRUG, 2000, pp. 197-229
Authors:
Yeh, JJ
Sellers, WR
Citation: Jj. Yeh et Wr. Sellers, PTEN - Regulator of phosphoinositide 3-kinase signal transduction, CANC DRUG, 2000, pp. 231-251
Authors:
Bernards, A
McClatchey, AI
Citation: A. Bernards et Ai. Mcclatchey, Neurofibromatoses, CANC DRUG, 2000, pp. 253-280
Authors:
Iliopoulos, O
Kaelin, WG
Citation: O. Iliopoulos et Wg. Kaelin, Von Hippel-Lindau disease - Clinical and molecular aspects, CANC DRUG, 2000, pp. 281-305
Authors:
Menke, AL
Hastie, ND
Citation: Al. Menke et Nd. Hastie, Wilms' tumor - A developmental anomaly, CANC DRUG, 2000, pp. 307-350
Authors:
Kuang, Y
Garcia-Higuera, I
Nisbet-Brown, E
Savoia, A
D'Andrea, AD
Citation: Y. Kuang et al., Fanconi anemia pathway and cancer susceptibility, CANC DRUG, 2000, pp. 351-373
Risultati:
1-14
|